Increased Levels of Runt-Related Transcription Factor 2 Are Associated With Poor Survival of Patients With Idiopathic Pulmonary Arterial Hypertension

Increased Levels of Runt-Related Transcription Factor 2 Are Associated With Poor Survival of Patients With Idiopathic Pulmonary Arterial Hypertension

Runt-related transcription factor 2 (RUNX2) plays a pivotal role in the pathogenesis of pulmonary arterial hypertension (PAH); yet, whether circulating levels of RUNX2 can predict survival of patients with idiopathic PAH (IPAH) is still unclear. The present study aimed to investigate the correlation...

Full description

Bibliographic Details
Main Authors:	Xuntao Yuan MD, Zuogang Wang MD, Lan Wang MD, Qinhua Zhao MD, Sugang Gong MD, Yuanyuan Sun MD, Qian Liu MD, Ping Yuan MD
Format:	Article
Language:	English
Published:	SAGE Publishing 2020-07-01
Series:	American Journal of Men's Health
Online Access:	https://doi.org/10.1177/1557988320945458

Similar Items

Better Outcomes in Pulmonary Arterial Hypertension After Repair of Congenital Heart Disease, Compared With Idiopathic Pulmonary Arterial Hypertension
by: Zhuoyuan Xu, MM, et al.
Published: (2021-07-01)

Topical Nanoemulsion of a Runt-related Transcription Factor 1 Inhibitor for the Treatment of Pathologic Ocular Angiogenesis
by: Santiago Delgado-Tirado, MD, et al.
Published: (2022-09-01)

Pulmonary artery dissection in long standing idiopathic pulmonary arterial hypertension: A case report
by: Luis Regalado, BS, MSc, et al.
Published: (2022-01-01)

The Impact of Abnormal Lipid Metabolism on the Occurrence Risk of Idiopathic Pulmonary Arterial Hypertension
by: Yaqin Wei, et al.
Published: (2023-09-01)

Huge idiopathic pulmonary artery aneurysm
by: Heon Sa-kong, MD, et al.
Published: (2017-06-01)

MiR-122-5p as a potential regulator of pulmonary vascular wall cell in idiopathic pulmonary arterial hypertension
by: Hui Zhao, et al.
Published: (2023-12-01)

Impact of Parthanatos on the Increased Risk of Onset and Mortality in Male Patients With Pulmonary Hypertension
by: Zhen-Chun Lv MD, et al.
Published: (2021-06-01)

Identifying key transcription factors and miRNAs coregulatory networks associated with immune infiltrations and drug interactions in idiopathic pulmonary arterial hypertension
by: Qian Li, et al.
Published: (2023-01-01)

Kidney Transplantation Confers Survival Benefit for Candidates With Pulmonary Hypertension
by: Michelle C. Nguyen, MD, MPH, et al.
Published: (2021-08-01)

Successful transcatheter embolization of an unruptured idiopathic peripheral pulmonary artery aneurysm
by: Chiaki Sato, MD, et al.
Published: (2023-01-01)

Ablation of Idiopathic Ventricular Tachycardia with a Left Bundle-Branch Block Morphology Originating from the Pulmonary Artery
by: Hiroshi Ogi, MD, et al.
Published: (2006-01-01)

Pulmonary Veno-Occlusive Disease: A Rare Cause of Pulmonary Hypertension
by: Said Hajouli MD, et al.
Published: (2019-04-01)

Pulmonary arterial hypertension associated with portal hypertension: Noninvasive comprehensive assessment using computed tomography
by: Hidetaka Hayashi, MD, et al.
Published: (2024-02-01)

Prognostic Value of Follicle-Stimulating Hormone Levels in Predicting Survival in Men With Idiopathic Pulmonary Arterial Hypertension
by: Qian Wang, et al.
Published: (2022-01-01)

Precapillary Pulmonary Arterial Hypertension Despite Contrary Anchoring Bias
by: Patrick Keller, MD, et al.
Published: (2023-09-01)

TET2 Variants in Japanese Patients With Pulmonary Arterial HypertensionNovel Teaching Points
by: Takahiro Hiraide, MD, et al.
Published: (2022-04-01)

Transcatheter Valve Implantation in Reversed Potts Shunt in Pulmonary Arterial Hypertension
by: Ghazaleh Goldar, MD, et al.
Published: (2022-12-01)

Eradication of Pulmonary Infection in a Child With Idiopathic Bronchiectasis
by: Sarah K. Anisowicz MD, et al.
Published: (2016-11-01)

Primary Presentation of Pulmonary Hypertension in the Peripartum
by: Malamo E. Countouris, MD, et al.
Published: (2020-01-01)

Atypical Causes of Severe Pulmonary Hypertension in Infancy
by: Myriam Almeida-Jones MD, et al.
Published: (2021-03-01)

CircGSAP regulates the cell cycle of pulmonary microvascular endothelial cells via the miR-942-5p sponge in pulmonary hypertension
by: Yuanyuan Sun, et al.
Published: (2022-08-01)

Larger pulmonary artery to ascending aorta ratios are associated with decreased survival of patients undergoing pulmonary endarterectomyCentral MessagePerspective
by: Panja M. Boehm, MD, et al.
Published: (2022-06-01)

Pregnancy in a Patient With Tetralogy of Fallot and Borderline Pulmonary Arterial Hypertension
by: Alexandra A. Frogoudaki, MD, PhD, et al.
Published: (2020-01-01)

Reversible Cardiac Hypertrophy in Pulmonary Arterial Hypertension Treated With High-Dose EpoprostenolNovel Teaching Points
by: Keiichi Izumi, MD, et al.
Published: (2022-09-01)

Liver Transplant Outcomes in Patients With Postcapillary Pulmonary Hypertension
by: Cerise Kleb, MD, et al.
Published: (2022-11-01)

Outcomes of total anomalous pulmonary venous drainage repair in neonates and the impact of pulmonary hypertension on survivalCentral MessagePerspective
by: Antonia Schulz, MD, et al.
Published: (2022-12-01)

Association Between the Early Discontinuation of Durvalumab and Poor Survival in Patients With Stage III NSCLC
by: Narek Shaverdian, MD, et al.
Published: (2021-07-01)

Long-term Outcomes and Predictors of Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Endarterectomy
by: Shuai Sun BS, et al.
Published: (2022-12-01)

Prophylactic function of excellent compliance with LTOT in the development of pulmonary hypertension due to COPD with hypoxemia
by: Wei Xiong, et al.
Published: (2018-04-01)

Short-Term Hemodynamic Effects of Apelin in Patients With Pulmonary Arterial Hypertension
by: Lauren Brash, MD, et al.
Published: (2018-04-01)

Pulmonary Arterial Hypertension in Glycogen Storage Disease Type I
by: Rachel D. Torok MD, et al.
Published: (2017-05-01)

Twelve-Year Survival in a Patient With Systemic Sclerosis–Associated Pulmonary Arterial Hypertension on Nifedipine Monotherapy
by: Scott A. Helgeson, MD, et al.
Published: (2019-09-01)

Percutaneous Interventional Therapy for Chronic Thromboembolic Pulmonary Hypertension
by: Ehtisham Mahmud, MD, et al.
Published: (2023-03-01)

Development and Validation of Diffuse Idiopathic Pulmonary Neuroendocrine Hyperplasia Diagnostic Criteria
by: Olga Sazonova, MD, MSc, et al.
Published: (2020-11-01)

Exercise right heart catheterization before and after balloon pulmonary angioplasty in inoperable patients with chronic thromboembolic pulmonary hypertension
by: Christoph B. Wiedenroth, MD, et al.
Published: (2020-08-01)

Evaluation of the Impact of an Echocardiographic Diagnosis of Pulmonary Hypertension on Patient Outcomes
by: Ping Yu Xiong, MD, et al.
Published: (2020-09-01)

Onset of rupioid psoriasis after vasodilatory regimen initiation in a patient with pulmonary arterial hypertension
by: Uros Rakita, MSc, et al.
Published: (2021-06-01)

Facemasks and Walk Distance in Pulmonary Arterial Hypertension Patients
by: Scott A. Helgeson, MD, et al.
Published: (2021-10-01)

CircALMS1 Alleviates Pulmonary Microvascular Endothelial Cell Dysfunction in Pulmonary Hypertension
by: Xiaoyi Hu, et al.
Published: (2024-03-01)

CircGSAP alleviates pulmonary microvascular endothelial cells dysfunction in pulmonary hypertension via regulating miR-27a-3p/BMPR2 axis
by: Yuanyuan Sun, et al.
Published: (2022-11-01)